1471 related articles for article (PubMed ID: 8172418)
1. Acute effect of hydralazine administration on pulmonary artery hemodynamics in dogs with chronic heartworm disease.
Atkins CE; Keene BW; McGuirk SM; Sato T
Am J Vet Res; 1994 Feb; 55(2):262-9. PubMed ID: 8172418
[TBL] [Abstract][Full Text] [Related]
2. Acute hemodynamic effects of hydralazine in dogs with chronic mitral regurgitation.
Kittleson MD; Johnson LE; Oliver NB
J Am Vet Med Assoc; 1985 Aug; 187(3):258-61. PubMed ID: 4030462
[TBL] [Abstract][Full Text] [Related]
3. Hydralazine pharmacodynamics in the dog.
Kittleson MD; Hamlin RL
Am J Vet Res; 1983 Aug; 44(8):1501-5. PubMed ID: 6625299
[TBL] [Abstract][Full Text] [Related]
4. Decreased pulmonary arterial endothelium-dependent relaxation in heartworm-infected dogs with pulmonary hypertension.
Matsukura Y; Washizu M; Kondo M; Motoyoshi S; Itoh A; Nakajyo S; Shimizu K; Urakawa N
Am J Vet Res; 1997 Feb; 58(2):171-4. PubMed ID: 9028484
[TBL] [Abstract][Full Text] [Related]
5. Effects of hyperbaric oxygen on ventricular performance, pulmonary blood volume, and systemic and pulmonary vascular resistance.
Abel FL; McNamee JE; Cone DL; Clarke D; Tao J
Undersea Hyperb Med; 2000; 27(2):67-73. PubMed ID: 11011796
[TBL] [Abstract][Full Text] [Related]
6. Influence of prostaglandin synthesis inhibitors on pulmonary vasodilatory effects of hydralazine in dogs with hypoxic pulmonary vasoconstriction.
Rubin LJ; Lazar JD
J Clin Invest; 1981 Jan; 67(1):193-200. PubMed ID: 7451649
[TBL] [Abstract][Full Text] [Related]
7. Haemodynamic effects of a selective adenosine A2A receptor agonist, CGS 21680, in chronic heart failure in anaesthetized rats.
Nekooeian AA; Tabrizchi R
Br J Pharmacol; 1998 Oct; 125(4):651-8. PubMed ID: 9831898
[TBL] [Abstract][Full Text] [Related]
8. Effects of CGS 21680, a selective A2A adenosine receptor agonist, on cardiac output and vascular resistance in acute heart failure in the anaesthetized rat.
Nekooeian AA; Tabrizchi R
Br J Pharmacol; 1998 Apr; 123(8):1666-72. PubMed ID: 9605574
[TBL] [Abstract][Full Text] [Related]
9. Dose-related cardiovascular effects of amrinone during enflurane anesthesia in the dog.
Makela VH; Kapur PA
Anesth Analg; 1986 Aug; 65(8):849-52. PubMed ID: 3729021
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular effects of hydralazine HCl administration in horses.
Bertone JJ
Am J Vet Res; 1988 May; 49(5):618-21. PubMed ID: 3395006
[TBL] [Abstract][Full Text] [Related]
11. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular effects of vasopressors in isoflurane-anesthetized dogs before and after hemorrhage.
Curtis MB; Bednarski RM; Majors L
Am J Vet Res; 1989 Nov; 50(11):1866-71. PubMed ID: 2619117
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic effects of amrinone in dogs anesthetized with halothane: comparison with isoproterenol and dobutamine.
Boncyk J; Redon D; Rusy B
Res Commun Chem Pathol Pharmacol; 1984 Jun; 44(3):347-54. PubMed ID: 6463363
[TBL] [Abstract][Full Text] [Related]
14. Systemic and coronary hemodynamic effects of pinacidil, a new antihypertensive agent, in awake dogs: comparison with hydralazine.
Kawashima S; Liang CS
J Pharmacol Exp Ther; 1985 Feb; 232(2):369-75. PubMed ID: 3968638
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiologic mechanism of cardiac dysfunction in experimentally induced heartworm caval syndrome in dogs: an echocardiographic study.
Atkins CE; Keene BW; McGuirk SM
Am J Vet Res; 1988 Mar; 49(3):403-10. PubMed ID: 3358551
[TBL] [Abstract][Full Text] [Related]
16. [The effect of Hongjingtian (Gadol) injection on cardiac hemodynamics and myocardial oxygen consumption of dogs].
Zhang ZH; Liu JS; Chu JN; Shang XH; Lin CR; Ma XB; Shi TR; Wang M; Wang YH; Li YR; Liu JH; Wu XY; Zhang XD; Zhang DS; Zhao ZH
Zhongguo Zhong Yao Za Zhi; 2005 Jul; 30(13):1001-5. PubMed ID: 16161429
[TBL] [Abstract][Full Text] [Related]
17. Oral hydralazine therapy for primary pulmonary hypertension.
Rubin LJ; Peter RH
N Engl J Med; 1980 Jan; 302(2):69-73. PubMed ID: 7350435
[TBL] [Abstract][Full Text] [Related]
18. Effects of hydralazine on cardiopulmonary function in canine low-pressure pulmonary edema.
Ghignone M; Girling L; Prewitt RM
Anesthesiology; 1983 Sep; 59(3):187-90. PubMed ID: 6881582
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects of buprenorphine in anesthetized dogs.
Martinez EA; Hartsfield SM; Melendez LD; Matthews NS; Slater MR
Am J Vet Res; 1997 Nov; 58(11):1280-4. PubMed ID: 9361893
[TBL] [Abstract][Full Text] [Related]
20. Characteristic cardiovascular effects of RA642, a pyrimido-pyrimidine derivative, in anesthetized dogs.
Koyama S
J Pharmacol Exp Ther; 1985 May; 233(2):480-4. PubMed ID: 3999030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
